Cannabis, cannabinoids, and health.

Lafaye Genevieve, et al.
Dialogues in clinical neuroscience, 2017

Abstract

Cannabis (also known as marijuana) is the most frequently used illicit psychoactive substance in the world. Though it was long considered to be a "soft" drug, studies have proven the harmful psychiatric and addictive effects associated with its use. A number of elements are responsible for the increased complications of cannabis use, including the increase in the potency of cannabis and an evolution in the ratio between the two primary components, Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (toward a higher proportion of Δ9-THC), Synthetic cannabinoid (SC) use has rapidly progressed over the last few years, primarily among frequent cannabis users, because SCs provide similar psychoactive effects to cannabis. However, their composition and pharmacological properties make them dangerous substances. Cannabis does have therapeutic properties for certain indications. These therapeutic applications pertain only to certain cannabinoids and their synthetic derivatives. The objective of this article is to summarize current developments concerning cannabis and the spread of SCs. Future studies must further explore the benefit-risk profile of medical cannabis use.

Keywords

cannabidiol; cannabis; medical cannabis; psychosis; synthetic cannabinoid; tetrahydrocannabinol.

Articles similar to "Cannabis, cannabinoids, and health."

• The properties of Cannabis Sativa: Hemp (Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction. (Non-drug varieties of Cannabis sativa L...)
• The properties of Cannabis Sativa: Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). (Hemp seed oil from Cannabis sativa L...)
• The properties of Cannabis Sativa: Cannabis sativa: Much more beyond Δ 9-tetrahydrocannabinol. (Cannabis is the most used illicit drug worldwide and its medicinal use is under discussion, being regulated in several countries...)
• The properties of Cannabis Sativa: Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. (Background and purpose: Epilepsy is the most prevalent neurological disease and is characterized by recurrent seizures...)
• The properties of Cannabis Sativa: Molecular Pharmacology of Phytocannabinoids. (Cannabis sativa has been used for recreational, therapeutic and other uses for thousands of years...)
• The properties of Cannabis Sativa: Pharmacology of cannabinoids in the treatment of epilepsy. (The use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use...)
• The properties of Cannabis Sativa: Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. (Increasing interest in the biology, chemistry, pharmacology, and toxicology of cannabinoids and in the development of cannabinoid medications necessitates an understanding of cannabinoid pharmacokinetics and disposition into biological fluids and tissues...)

Previous article

Barley grass juice (Hordeum vulgare L.) inhibits obesity and improves lipid profile in high fat diet-induced rat model.

Next article

Phycochemical constituents and biological activities of Fucus spp.